46. On August 28, 2017, Mirna Therapeutics, Inc.

(renamed “Synlogic” after the deal), announced a business combination with Synlogic, Inc. Form 8-K for Synlogic (NASDAQ ticker SYBX, cik 0001667986) describes the transaction and was filed with the SEC and completed on August 28, 2017. You can access Form 8-K at the SEC’s Investor website:
(https://www.sec.gov/Archives/edgar/data/12818 95/000119312517283239/d421363d8k.htm). Read “Item 1.01, Entry into a Material Definitive Agreement,” and determine which form of merger was used to effect the acquisition.